TFF Pharmaceuticals Equity 2024

TFF Pharmaceuticals Aktienanalyse

What does TFF Pharmaceuticals do?

TFF Pharmaceuticals Inc is a biopharmaceutical company founded in 2018 and based in Austin, Texas. The company specializes in the development of inhalable drugs based on Thin Film Freezing technology. The history of TFF Pharmaceuticals began with the merger of two companies, Peloton Therapeutics and Infini Exploration. As a result of this fusion, the present-day TFF Pharmaceuticals was created. Since then, the company has experienced rapid growth and has become a leading provider of innovative inhalable medications. TFF Pharmaceuticals' business model includes the development and marketing of inhalable drugs based on patented Thin Film Freezing technology. This technology enables the production of medications in the form of nanoparticles that can be easily inhaled into the respiratory system. As a result, the drugs can directly reach the affected area of the lungs and have an immediate effect. TFF Pharmaceuticals' portfolio includes various areas such as oncology, respiratory diseases, infectious diseases, and rare diseases. The company is currently developing a variety of products in these areas, which have a significant market demand and can improve patients' quality of life. One example of a TFF Pharmaceuticals product is the inhalable medication Voriconazole-TFF. It is an innovative formulation of Voriconazole, an antifungal used for fungal infections. Voriconazole-TFF achieves a higher concentration in lung tissue and thus has a higher effectiveness than conventional Voriconazole products. The medication has been approved by the U.S. Food and Drug Administration (FDA) and is already on the market. Another example is the inhalable medication Tacrolimus-TFF, which is being developed for the treatment of lung transplant rejections. The Thin Film Freezing technology enables the production of Tacrolimus in nanoparticles that can directly reach the lungs and activate immunosuppression specifically there. TFF Pharmaceuticals closely collaborates with various partners to successfully market its products. These include pharmaceutical companies that take over the marketing of the products in different countries, as well as research institutes and medical facilities that work with TFF Pharmaceuticals to further develop its technology and products. Overall, TFF Pharmaceuticals is an innovative company specialized in the development of inhalable medications. With its patented Thin Film Freezing technology, the company has quickly made a name for itself and successfully brought its products to the market. TFF Pharmaceuticals' products have the potential to improve the lives of millions of patients worldwide, and the company will continue to play an important role in the pharmaceutical industry. TFF Pharmaceuticals ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing TFF Pharmaceuticals's Equity

TFF Pharmaceuticals's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding TFF Pharmaceuticals's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating TFF Pharmaceuticals's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

TFF Pharmaceuticals's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in TFF Pharmaceuticals’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about TFF Pharmaceuticals Stock

What is the equity of TFF Pharmaceuticals this year?

TFF Pharmaceuticals has equity of 9.57 M USD this year.

What was the equity of TFF Pharmaceuticals compared to the previous year?

The equity of TFF Pharmaceuticals has increased/decreased by -58.19% decreased compared to the previous year.

What impact does a high equity have on investors of TFF Pharmaceuticals?

A high equity is advantageous for investors of TFF Pharmaceuticals as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of TFF Pharmaceuticals?

A low equity can be a risk for investors of TFF Pharmaceuticals, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of TFF Pharmaceuticals affect the company?

An increase in equity of TFF Pharmaceuticals can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of TFF Pharmaceuticals affect the company?

A reduction in equity of TFF Pharmaceuticals can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of TFF Pharmaceuticals?

Some factors that can affect the equity of TFF Pharmaceuticals include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of TFF Pharmaceuticals so important for investors?

The equity of TFF Pharmaceuticals is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can TFF Pharmaceuticals take to change the equity?

To change equity, TFF Pharmaceuticals can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does TFF Pharmaceuticals pay?

Over the past 12 months, TFF Pharmaceuticals paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, TFF Pharmaceuticals is expected to pay a dividend of 0 USD.

What is the dividend yield of TFF Pharmaceuticals?

The current dividend yield of TFF Pharmaceuticals is .

When does TFF Pharmaceuticals pay dividends?

TFF Pharmaceuticals pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of TFF Pharmaceuticals?

TFF Pharmaceuticals paid dividends every year for the past 0 years.

What is the dividend of TFF Pharmaceuticals?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is TFF Pharmaceuticals located?

TFF Pharmaceuticals is assigned to the 'Health' sector.

Wann musste ich die Aktien von TFF Pharmaceuticals kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of TFF Pharmaceuticals from 5/24/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 5/24/2024.

When did TFF Pharmaceuticals pay the last dividend?

The last dividend was paid out on 5/24/2024.

What was the dividend of TFF Pharmaceuticals in the year 2023?

In the year 2023, TFF Pharmaceuticals distributed 0 USD as dividends.

In which currency does TFF Pharmaceuticals pay out the dividend?

The dividends of TFF Pharmaceuticals are distributed in USD.